MAR 28, 2020 8:39 AM PDT

The Antibody Test to See if You've Already Had the Coronavirus

WRITTEN BY: Annie Lennon

Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiologists map out the spread of the virus. Now, Henry Schein Inc, the world’s largest distributor of dental and medical supplies, has released an antibody rapid blood test that can tell you if you’ve had the coronavirus before. And it does this in less than 15 minutes. 

Known as Standard Q COVID-19 IgM/IgG Rapid Test, it is a rapid immunochromatography test designed to detect specific IgM and IgG antibodies associated with the novel coronavirus from blood drawn by a pinprick. Detecting the presence of these antibodies, when taken with other information including the presence of symptoms and medical history, the test allows medical professionals to tell whether a person has already been infected by the virus, and whether they may be currently infected by it too. 

Currently available under emergency guidance by the US Food and Drug Administration, Stanley M Bergman, chairman of the Board and CEO of Henry Schein said, “This pandemic is an unprecedented situation, and making rapid diagnostic tools available to health care professionals is critical for detecting and mitigating the spread of the coronavirus.”

Other private companies have also begun selling blood tests capable of detecting coronavirus antibodies. For example, California-based Biomerica sells its tests for less than $10, and has already had orders placed from Europe and the Middle East. Chembio Diagnostics from New York has reportedly received an order for $4 million- worth of antibody tests against the virus, while South Korean test maker, Sugantech, is also reportedly producing tests. 

Meanwhile, researchers are also investigating the viability of antibody tests. Fatima Amanat, a PhD candidate at the Icahn School of Medicine at Mount Sinai, is currently developing tests for first responders and healthcare providers in particular. She said,  “Right now, if you have a highly infectious COVID-19 patient, it's really a problem to send a nurse who is not immune to it already because she’s so susceptible. Our test would be for all the doctors and healthcare providers, to see if they're already immune to it and have antibodies.”



Sources: US Dental Tribune, Vice and Reuters 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Are COVID-19 Antibody Tests a Back-to-Work Pass?
Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. ...
APR 15, 2020
Immunology
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Experimental Drug Prevents Cancer Relapse
One of the main challenges of cancer treatments is preventing the cancer from returning again—in essence stopping ...
MAY 03, 2020
Drug Discovery & Development
MAY 03, 2020
Hydroxychloroquine: The Controversial Use
COVID-19 was declared a public health threat on January 30th and since then it took the world by a storm with more than ...
MAY 16, 2020
Cancer
MAY 16, 2020
Red Blood Cells: More than just an Oxygen Delivery Service
The human body is a complex network of systems that often interact and affect each other. Recent work shows that red blo ...
MAY 14, 2020
Cancer
MAY 14, 2020
New hope for immunotherapy for pediatric brain cancer
Pediatric brain cancer is an especially tough pill to swallow. While one in four children does not survive medulloblasto ...
Loading Comments...